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Abstract A respiratory-deficient mutant of Candida al-
bicans MEN was generated by culturing cells in medium
supplemented with ethidium bromide at 37 °C for 5 days.
The respiratory-deficient mutant (C. albicans MMU11)
was incapable of growth on glycerol, had a reduced oxy-
gen uptake rate and demonstrated an altered mitochondrial
cytochrome profile. Respiratory-competent cybrids were
formed by mitochondrial transfer following fusion of pro-
toplasts with those of C. albicans ATCC 44990. Mutant
MMU11 possessed lower levels of ergosterol than the
parental isolates and the cybrids, and demonstrated a
small but statistically significant increase in tolerance to
amphotericin B. The results demonstrated that disruption
of mitochondrial function in C. albicans increases the tol-
erance to amphotericin B, possibly mediated by a reduc-
tion in cellular ergosterol content.
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Introduction
The dimorphic yeast Candida albicans is an opportunistic
fungal pathogen and the dominant cause of candidosis in
humans (Pfaller et al. 1998). There has been a consider-
able increase in the incidence of disease attributable to
this yeast in recent years due to the spread of AIDS, the
widespread use of immuno-suppressive therapy and the
prolonged survival of patients with critical illnesses
(Lunel et al. 1999). The emergence of C. albicans isolates
resistant to anti-fungal drugs has serious implications for
the continued success of conventional anti-fungal therapy.
A number of Candida isolates manifesting anti-fungal drug
resistance have been characterised as being respiratory-
deficient i.e. incapable of aerobic respiration (Defontaine
et al. 1999). Respiratory-deficient isolates of Candida gla-
brata demonstrate tolerance to polyene (Geber et al. 1995)
and azole anti-fungal drugs (Bouchara et al. 2000).
Respiratory-deficient mutants (frequently referred to
as petite mutants) are difficult to isolate in C. albicans
(Aoki and Ito-Kuwa 1987; Abu-Hatab and Whittaker 1992)
whereas they arise spontaneously in Saccharomyces cere-
visiae at a rate of approximately 0.1% of cells per genera-
tion. S. cerevisiae petite mutants grow at a lower rate than
their parents and are incapable of metabolising glycerol,
have disrupted cytochromes and reduced rates of oxygen
consumption (Gyurko et al. 2000; Aoki et al. 1990).
Respiratory competency can be restored to respiratory-
deficient cells by transfer of the mitochondrion from a
donor strain through protoplast fusion (Kavanagh and
Whittaker 1996). A mitochondrion donor from a closely
related strain (intra-specific transfer) or, in some cases, a
mitochondrion from a different species (inter-specific trans-
fer) can restore some respiratory function (Spirek et al.
2000). Mitochondrial transfer opens the possibility of ex-
amining the role of the mitochondrion in yeast virulence
and anti-fungal drug susceptibility by allowing the cre-
ation of novel strains with the same nuclear background
as the parent strain but with a different mitochondrial
genome.
The objective of the work presented here was to estab-
lish the role of the mitochondrion in regulating the anti-
fungal drug susceptibility of C. albicans by firstly creat-
ing a respiratory-deficient mutant and then restoring re-
spiratory function by mitochondrion transfer following
protoplast fusion.
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Materials and methods
Yeast isolates
Candida albicans MEN (serotype B, originally isolated from an
eye infection and a gift from Dr. D. Kerridge, Cambridge, UK) and
ATCC 44990 (ade, thr) (from the American Type Culture Collec-
tion, Manasas, Va., USA) were used as the parental isolates. A re-
spiratory-deficient mutant, MMU11, was created using ethidium
bromide mutagenesis of C. albicans MEN. Three cybrids (num-
bers 3, 26 and 27) were created by fusion of protoplasts of C. albi-
cans MMU11 and 44990.
Culture conditions
Cultures were grown in YEPD broth [2% (w/v) glucose (Sigma-
Aldrich), 2% (w/v) bactopeptone (Difco), 1% (w/v) yeast extract
(Oxoid] or minimal medium (MM) [2% (w/v) glucose, 0.17%
(w/v) yeast nitrogen base (without amino acids and ammonium
sulfate) (Difco) and 0.5% (w/v) ammonium sulfate]. Where appro-
priate, adenine and threonine were added to MM to allow growth
of C. albicans 44990. Media were solidified by the addition of 2%
(w/v) agar (Oxoid). YEPG plates had the same constituents as
YEPD but with 2% (w/v) glycerol replacing 2% (w/v) glucose.
Isolation of respiratory-deficient mutants
Respiratory-deficient mutants were obtained by culturing C. albi-
cans MEN for 5 days at 37 °C and 200 rpm in an orbital incubator
in YEPD broth supplemented with 25 μg ethidium bromide
(Sigma-Aldrich) ml–1 as described (Aoki and Ito-Kuwa 1987).
Respiratory-deficient mutants were selected by their inability to
grow on glycerol.
Protoplast isolation and fusion
Protoplasts were isolated by enzymatic digestion of the cell walls
of C. albicans MMU11 and 44990 as described (Kavanagh et al.
1991). Protoplasts of C. albicans MMU11 and 44990 were fused
by resuspending 1×107 protoplasts of each strain in 60% (w/v)
PEG 3350 (Sigma-Aldrich) and 0.l M calcium acetate as described
(Kavanagh et al. 1991). The negative control consisted of a similar
number of protoplast pairs, but mixed in the absence of PEG and
calcium acetate. Protoplasts (1×106) were embedded in molten 
(47 °C) osmotically stabilised MM containing glycerol as the car-
bon source and incubated at 30 °C for 7 days. Cybrids were identi-
fied as being capable of metabolising glycerol (unlike mutant
MMU11) and of growing in the absence of the requirements of
C. albicans 44990. The cybrid fusion frequency was expressed as
the number of cybrids formed as a percentage of the number of
pairs of parental protoplasts in the fusion mixture.
Amphotericin B susceptibility testing
Yeast cultures were grown to the stationary phase in antibiotic me-
dium 3 (AB 3) (Oxoid) overnight at 30 °C and 200 rpm, harvested
by centrifugation (2,220xg for 5 min in a Beckmann GS-6 cen-
trifuge) and diluted to 1×106 cells ml–1. Cells (1×105 in 100 μl)
were added to each well of a 96-well plate containing amphotericin
B (Sigma-Aldrich) ranging from 0.0048 to 2.5 μg ml–1 in AB3.
The plates were incubated at 37 °C for 24 h and the optical density
was read at 540 nm using a microplate reader. The MIC90 was de-
termined to be the lowest concentration of amphotericin B required
to reduce growth by 90% relative to the control (Moran et al.
1997).
Cytochrome analysis
Stationary phase cells (2×1010) were harvested by centrifugation
and washed twice in phosphate-buffered saline (PBS, pH 7.2). Half
of the sample was oxidised by suspension in 20 ml of 0.3% (w/v)
sodium hypochlorite (Sigma-Aldrich). The cells were harvested by
centrifugation and resuspended in 50% (v/v) glycerol. The remain-
ing 1×1010 cells were resuspended in 50% (v/v) glycerol to which
a few crystals of sodium dithionite (Merck, Darmstadt, Germany)
were added to reduce the cells. Reduced-oxidised differential spec-
tra were measured on a dual-beam Cary IE UV-Visible spec-
trophotometer over the range 500–650 nm.
Measurement of oxygen uptake
Stationary phase cells (approximately 1.5×108 cells ml–l) grown in
YEPD broth at 30 °C overnight were harvested, washed with PBS
and resuspended in 25 mM phosphate buffer (pH 7.2) at a density
of 5×108 ml–1. Oxygen uptake measurements were made at 30 °C
using a Clark-type oxygen electrode. Oxygen uptake rates were
calculated as μmol oxygen consumed (108 cells)–I (min)–I.
Sterol extraction and analysis
Sterols were extracted using the method of Arthington-Skaggs et
al. (1999) with slight modifications. Stationary phase cells (1 g wet
weight) were harvested and washed with PBS. Cells were resus-
pended in 2 ml of 20% (w/v) KOH and 60% (v/v) ethanol and
placed in a shaking water bath (80–90 °C) for 90 min. N-heptane
was added to the solution, which was agitated for 10 s and the
aqueous layer was removed. The sterol content was quantified us-
ing a gas chromatograph (Hewlett Packard 5890 Series II) with a
flame ionisation detector and a Chromapack capillary column
(Chromapack International BV, Middelburg, The Netherlands) op-
erated isothermally at 300 °C. Injector and detector temperatures
were 320 °C and the carrier gas was N2.
Statistical analysis
Data accumulated for each figure were analysed by t tests (nor-
mality and equal variance tests) and the Kruskal Wallis test. The
SigmaStat Statistical Analysis System (version 1.00) was used
throughout. Each experiment was carried out on three independent
occasions and results are presented as the mean±standard devia-
tion.
Results
Isolation of respiratory-deficient mutant 
and generation of cybrids
Growth of C. albicans MEN in YEPD broth supplemented
with ethidium bromide (25 μg ml–1) at 37 °C was used to
obtain a respiratory-deficient mutant. Approximately 2,500
potential respiratory-deficient colonies were tested for
respiratory status by screening on YEPD and YEPG plates.
One isolate (MMU11) was identified as being respiratory-
deficient by its inability to grow on glycerol. Replacing
the damaged mitochondrion of a respiratory-deficient mu-
tant with a fully functional mitochondrion from a donor
strain results in a respiratory competent cybrid that resem-
bles the original parent (Maraz and Ferenczy 1980; Richards
et al. 1987). Protoplasts of C. albicans MMU11 and 44990
were prepared by enzymatic degradation of the cell walls
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and fused using PEG and calcium cations. Cybrids were
selected on MM containing glycerol as the carbon source.
The cybrid fusion frequency was calculated to be 1.64×
10–2 % while the reversion rate of C. albicans 44990 to
protrophy on the same medium was 2.33×10–7 %. The three
fastest-growing putative cybrids (numbered 3, 26 and 27)
were selected for further analysis. The parental strains
(C. albicans MEN and 44990), mutant MMU11 and the cy-
brids were assessed for their ability to grow on glycerol.
C. albicans MEN and 44990 and the three cybrids grew
on this carbon source while the respiratory-deficient mu-
tant, MMU11, was incapable of growth. In all subsequent
work, stocks of the three cybrids were kept on MM-glyc-
erol in order to maintain selection pressure and prevent re-
version or selective loss of the mitochondrion.
Determination of respiratory status of C. albicans strains
The mitochondrion is the site of oxidative phosphoryla-
tion within the eukaryotic cell, and one component of this
process is the electron transfer chain, which involves a
number of cytochromes. Cytochromes may be nuclear
and/or mitochondrially encoded. For example, three of the
seven subunits of cytochrome aa3 are mitochondrially en-
coded (Whittaker and Danks 1978), so it is conceivable
that a respiratory-deficient mutant with disrupted mito-
chondrial function might have an altered cytochrome pro-
file. Reduced minus oxidised difference spectra were ob-
tained using a dual-beam spectrophotometer to record al-
terations in the relative amounts of the cytochromes in
C. albicans MEN, mutant MMU11 and the three cybrids.
Cytochromes aa3 (602 nm), b (564 nm) and c (550–554 nm)
are present in C. albicans MEN, but major alterations are
evident in mutant MMU 11 (Fig. 1). While the cybrids
possessed restored cytochrome profiles some alterations
are still evident, for example in cybrid 26, but the alter-
ations are less dramatic than those seen in mutant MMU11.
Disruption of the mitochondrial cytochrome content of
a cell has the potential to reduce its respiratory efficacy,
while restoration of respiratory function following trans-
fer of a mitochondrion by protoplast fusion has the capac-
ity to restore, partially or completely, respiratory status
(Ferenczy and Maraz 1977; Maraz and Ferenczy 1980).
The oxygen uptake rate demonstrated by mutant MMU11
was 9.3±0.54 μmol of oxygen consumed (108 cells)–1 min–1
while that of C. albicans MEN was 54.2±6.1 μmol of oxy-
gen consumed (108 cells)–1 min–1 C. albicans 44990 had
an oxygen uptake rate of 26.2±5.58 μmol of oxygen con-
sumed (108 cells–1)min–1. The cybrids demonstrated a res-
piration rate intermediate between that of C. albicans
MEN and 44990, ranging from 32.4±1.5 (cybrid 3) to 45.7±
1.56 (cybrid 27) μmol of oxygen consumed (108 cells–1)
min–1 (Fig. 2). Analysis of these results using the normal-
ity test indicated a statistically significant difference at
p<0.001 between the oxygen uptake rate of C. albicans
MEN and that of the other strains tested.
Amphotericin B susceptibility of C. albicans strains
Respiratory-deficient cells of C. glabrata have previously
been shown to manifest an increased tolerance to azole
anti-fungal drugs (Defontaine et al. 1999; Bouchara et al.
2000), and respiratory-deficient mutants of C. albicans show
enhanced tolerance to the anti-microbial peptide histatin 5
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Fig. 1 Cytochrome profiles of Candida albicans strains. Differen-
tial cytochrome profiles of stationary-phase cells of C. albicans
were obtained as described by scanning in a dual-beam spectro-
photometer from 500–650 nm
Fig. 2 Oxygen consumption of C. albicans strains. Oxygen con-
sumption was measured using a Clark-type oxygen electrode and
expressed as μmol oxygen consumed (108 cells)–1 min–1. All val-
ues are the mean of three independent determinations±standard
deviation of the mean. A statistically significant difference com-
pared to C. albicans MEN is indicated by *
(Gyurko et al. 2000). The appearance of azole resistance
in C. glabrata has been attributed to the up-regulation of
CgCDR1 and CgCDR2 in response to the absence of a
functional mitochondrion (Sanglard et al. 2001). The re-
sponses of C. albicans MEN, 44990, mutant MMU11 and
the cybrids to the anti-fungal drug amphotericin B were
measured. An amphotericin B concentration of 0.051±
0.004 μg ml–1 corresponded to the MIC90 value for mutant
MMU11, while the respiratory competent strains MEN
and 44990 had MIC90 values of 0.039±0.003 and 0.038±
0.003 μg ml–1, respectively (Fig. 3). The amphotericin B
MIC90 values for the three cybrids ranged from 0.031±
0.004 (cybrid 27) to 0.037±0.003 (cybrid 3) μg ml–1. Sta-
tistical analysis of these results using both t tests (i.e. nor-
mality and equal variance tests) indicated a statistically
significant difference between the MIC90 value obtained
for MEN and mutant MMU11 at p=0.01 but no significant
difference at p=0.174 between the value obtained for
MEN and those obtained for C. albicans 44990 and the
cybrids. This indicates that, in the absence of a functional
mitochondrion, the respiratory-deficient mutant shows a
statistically significant increase in tolerance to ampho-
tericin B, but that in normally respiratory-competent iso-
lates (MEN, 44990) and in those constructed by proto-
plast fusion (cybrids 3, 26 and 27), this tolerance is ab-
sent.
Determination of ergosterol content 
of C. albicans strains
The anti-fungal agent amphotericin B acts by binding to
ergosterol, the chief sterol found in the fungal cell mem-
brane. This results in the formation of channels in the
membrane, which leads to metabolite leakage, acidifica-
tion of the cytoplasm and cell death (Abu Salah 1996). 
A reduction in sterol production may represent a mecha-
nism for tolerance of amphotericin B since a diminution
in ergosterol results in fewer binding sites for the drug
(Kelly et al. 1997). The ergosterol content of the parents,
mutant MMU11 and the three cybrids was assessed as de-
scribed. The results reveal the lowest levels of ergosterol
in mutant MMU11 [0.18±0.02 mg (gwet wt.)–1, Fig. 4]. In
contrast, the parent strains C. albicans MEN and 44990
exhibited levels substantially greater than that of MMUl1
at 0.26±0.04 and 0.29±0.02 mg (gwet wt.)–1, respectively,
while the cybrids possessed ergosterol levels ranging
from 0.22±0.01 to 0.26±0.05 mg (gwet wt.)–1. Examina-
tion of these results revealed a significant difference be-
tween the ergosterol content of C. albicans MEN and that
of mutant MMU11 at p=0.028 using a normality t test. In
contrast, there was no significant difference at p=0.258
between C. albicans MEN and C. albicans 44990 and the
cybrids. This latter comparison also failed the Kruskal-
Wallis test.
Discussion
A respiratory-deficient mutant (MMU11) of C. albicans was
obtained by culturing cells at 37 °C for 5 day in the pres-
ence of 25 μg ethidium bromide ml–1. Such culture con-
ditions are capable of rendering entire populations of
S. cerevisiae respiratory deficient (Ferguson and von Borstel
1992), but the isolation of respiratory-deficient mutants of
C. albicans is a low-frequency event (Abu Hatab and
Whittaker 1992), possibly because the mutation proves
lethal for the majority of such C. albicans mutants. Ethid-
ium bromide is a DNA-intercalating agent that inhibits
mitochondrial DNA replication, leading to a cell inca-
pable of metabolising glycerol as a carbon source and of
respiring and with a dysfunctional electron transport chain
(Goldering et al. 1970; Ferguson and Von Borstel 1992).
Disruption of mitochondrial function results in an altered
cytochrome profile since three of the seven subunits of
cytochrome aa3 are mitochondrially encoded (Whittaker
and Danks 1978). Disruption of cytochromes leads to an
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Fig. 3 Susceptibility of C. albicans strains to amphotericin B. The
MIC90 was calculated as the concentration of amphotericin B that
inhibited growth by 90% relative to the control. All values are the
mean±standard deviation of three independent assays. A statisti-
cally significant difference relative to C. albicans MEN is indi-
cated by *. The absence of a statistically significant difference
compared to C. albicans MEN is indicated by **
Fig. 4 Ergosterol content of C. albicans strains. Ergosterol was
extracted from cells as described and quantified by GC analysis.
Values are expressed as ergosterol [mg/g cells (wet wt.)]. All val-
ues are the mean±standard deviation of three independent assays.
A statistically significant difference relative to C. albicans MEN is
indicated by *. The absence of a statistically significant difference
is indicated by **
inefficient electron transfer pathway and a concomitant
reduction in respiration efficiency.
Respiratory competency was restored to mutant MMU11
by fusion with protoplasts of C. albicans 44990. Proto-
plast fusion has been employed previously to restore re-
spiratory competency to petite cells of S. cerevisiae (Maraz
and Ferenczy 1980) and offers the possibility of transfer-
ring intact organelles (e.g. the mitochondrion) between
cells (Ferenczy and Maraz 1977). The selection condi-
tions employed here screened for the transfer of mito-
chondria in the construction of the cybrids, rather than the
transfer of chromosomes, which is a far rarer event (Ka-
vanagh and Whittaker 1996). Cybrids demonstrated a re-
stored respiratory status, but some characteristics (e.g.
oxygen uptake) were intermediate between those evident
in both parents. The cybrids were capable of growing on
glycerol, had a respiration rate greater than that of mutant
MMU11 but intermediate between C. albicans 44990 and
MEN and the three cybrids demonstrated partially re-
stored cytochrome profiles.
The response of C. albicans MEN, 44990, MMU11
and the cybrids to amphotericin B was assessed. Mutant
MMU11 was the most tolerant of this anti-fungal (MIC90
0.051 μg ml–1) while the cybrids were the most sensitive,
having MIC90 values of 0.031–0.037 μg ml–1 (Fig. 3). The
parents (MEN and 44990) had amphotericin B MIC90 val-
ues of 0.039 and 0.038 μg ml–1, respectively. Reductions in
sterol levels in C. albicans have been identified as a
mechanism for increased growth in the presence of am-
photericin B (Kelly et al. 1997). Amphotericin-B-tolerant
C. albicans has been described previously and tolerance
was attributed to a reduction in the ergosterol content of
the fungal cell membrane (White et al. 1998). Disruptions
of the genes in the ergosterol biosynthesis pathway leads
to decreased ergosterol in C. glabrata and an increase in
drug tolerance, particularly to amphotericin B (Geber et
al. 1995; Vazquez et al 1996). Analysis of the ergosterol
content of the strains constructed here demonstrated 
that mutant MMU11 had the lowest level of ergosterol
compared to C. albicans 44990 and MEN. The cybrids
demonstrated an amount of ergosterol greater than mutant
MMU11 but lower than that of the parents. The involve-
ment of a functional mitochondrion in ergosterol biosyn-
thesis is well characterised and arises from the provision
of NADPH for squalene dimerisation (Parks and Casey
1995). In addition, ERG1 encodes squalene epoxidase
which converts squalene to 2, 3 oxidosqualene. This is an
oxygen-dependent step and in a respiratory-deficient mu-
tant there would be little synthesis of ergosterol (Daum et
al. 1998) thus leading to the reduced ergosterol content
evident in mutant MMU11. While mutant MMU11 was
characterised as respiratory-deficient, it still retained some
respiratory capacity (Fig. 2), which may explain the pres-
ence of reduced levels of ergosterol (Fig. 4) within the
cell. The complete destruction of respiratory function
would lead to a depletion of NADPH required for ergos-
terol biosynthesis and a concomitant loss of ergosterol
from the cell membrane. This could have the effect of giv-
ing an enhanced tolerance to amphotericin B.
These results demonstrate that the mitochondrion plays
a central role in governing the susceptibility of C. albi-
cans to amphotericin B by regulating the ergosterol con-
tent of the plasma membrane. Respiratory-deficient mu-
tants of C. glabrata have been isolated clinically and im-
plicated in the failure of anti-fungal therapy due to ele-
vated resistance to azole anti-fungal drugs (Defontaine et
al. 1999; Bouchara et al. 2000). Resistance in this case
was explained by elevated expression of genes coding for
drug efflux pumps in response to the loss of a functional
mitochondrion (Sanglard et al. 2001). While the respira-
tory-deficient mutant isolated here demonstrated elevated
tolerance to amphotericin B, those isolated by Defontaine
et al. (1999) and Bouchara et al. (2000) did not. This may
be attributable to the fact that ethidium bromide mutagen-
esis can yield a range of different respiratory-deficient mu-
tants in yeast and that, while the majority of the genome
may be destroyed, small fragments can be retained and
amplified to give a mitochondrial DNA content equiva-
lent in size to that of the wild type (Whittaker and Danks
1978). As a consequence, different mitochondrial genes
can be retained even in a cell incapable of respiration. It is
possible that the respiratory-deficient mutants of De-
fontaine et al. (1999) and Bouchara et al. (2000) mani-
fested no alteration in cellular ergosterol content while the
one generated here (mutant MMU11) manifested a de-
creased ergosterol content and a concomitant increase in
tolerance to amphotericin B. In addition, while the respi-
ratory-deficient mutants of C. glabrata isolated by De-
fontaine et al. (1999) were relatively easily isolated, the
equivalent mutant produced here required exposure to
ethidium bromide for 5 days and was the only mutant iso-
lated from 2,500 potentially respiratory-deficient colonies.
This indicates that the mitochondria of C. glabrata and
C. albicans have different sensitivities to ethidium bromide
mutagenesis and possibly yield different types of respira-
tory-deficient mutants.
In the work presented here, a small but statistically
significant elevation in the tolerance of a respiratory-
deficient mutant of C. albicans to amphotericin B was
achieved and this tolerance could be removed by restora-
tion of respiratory function following mitochondrial trans-
fer via protoplast fusion. The ability to create respiratory-
deficient mutants and to restore respiratory competency
through protoplast fusion opens the possibility of examin-
ing the interaction of the nuclear and mitochondrial
genomes in regulating fungal pathogenicity and drug sus-
ceptibility.
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